Markets.com Logo

CYTK

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    37.1648$
  • Previous Close
    37.922$
  • 52 Week Change
    30.08$
  • Day Range
    -0.76$
  • 52 Week High/Low
    29.31$ - 59.39$
  • Dividend Per Share
    --
  • Market cap
    4 466 M$
  • EPS
    -1.12
  • Beta
    0.648
  • Volume
    --

About

CYTK.US is the stock ticker symbol for Cytokinetics, Incorporated, a biopharmaceutical company focused on discovering, developing, and commercializing muscle activators and muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised. Cytokinetics is headquartered in South San Francisco, California and its common stock is listed on the Nasdaq Global Select Market. The company's research and development efforts are primarily concentrated on potential therapies for diseases like amyotrophic lateral sclerosis (ALS), hypertrophic cardiomyopathy (HCM), and spinal muscular atrophy (SMA).
NBIS Stock Outlook for 2026: What will be the future of Nebius Group?

NBIS Stock Outlook for 2026: What will be the future of Nebius Group?

Frances Wang|--
Commodity market today: Will Gold (XAU/USD) and Silver (XAG) hit new highs?

Commodity market today: Will Gold (XAU/USD) and Silver (XAG) hit new highs?

Frances Wang|--
RGTI stock crashed 7% today: what’s happening with Rigetti Computing?

RGTI stock crashed 7% today: what’s happening with Rigetti Computing?

Frances Wang|--
Gold price analysis: XAU/USD price today, how high will gold go in 2026?

Gold price analysis: XAU/USD price today, how high will gold go in 2026?

Frances Wang|--
Technology stock to watch in 2026: What is the new NVDA stock price target?

Technology stock to watch in 2026: What is the new NVDA stock price target?

Frances Wang|--
BMNR stock up 9% today: what’s going on with BitMine Immersion Technologies?

BMNR stock up 9% today: what’s going on with BitMine Immersion Technologies?

Frances Wang|--
Solana (SOL) price analysis: What will SOL/USD be worth in 2026?

Solana (SOL) price analysis: What will SOL/USD be worth in 2026?

Frances Wang|--

Factors

Drug Development Progress: Positive clinical trial results for Cytokinetics' heart failure drug, aficamten, tend to increase stock price. Conversely, trial failures or delays can negatively impact it.

Regulatory Decisions: FDA approval or rejection of aficamten significantly influences the stock. Approval leads to increased revenue potential and higher stock value.

Competition: Competing therapies for heart failure affect Cytokinetics' market share and profitability, thus influencing stock price.

Market Sentiment: General investor optimism or pessimism regarding biotech stocks influences Cytokinetics' valuation.

Financial Performance: Quarterly earnings reports, revenue growth, and profitability impact investor confidence and stock price.

Partnerships and Collaborations: Strategic alliances with pharmaceutical companies often boost investor confidence and stock value.

Economic Conditions: Broad economic factors like interest rates and inflation influence investor behavior and the overall stock market, including CYTK.US.

People Also Watch

Latest news

ESMA Expansion Sparks Crypto, Fintech Slowdown Concerns in EU

Noah Lee|--

Bitcoin's 'Santa' Rally: Fed Rate Decision and 2026 Outlook

Noah Lee|--

Western Union Unveils Stable Card, Stablecoin Strategy to Combat Inflation

Liam James|--

Latest Education Articles

A Complete Guide to Cryptos: How to Invest in Crypto as A BEGINNER In 2026?

A Complete Guide to Cryptos: How to Invest in Crypto as A BEGINNER In 2026?

Ghko B|--
Contracts for Difference explained: What is CFD trading, how do CFDs work?

Contracts for Difference explained: What is CFD trading, how do CFDs work?

Ghko B|--
Financial market for beginners: How financial markets work, how to invest?

Financial market for beginners: How financial markets work, how to invest?

Ghko B|--